sleep apnea tirzepatide FDA approves to treat Sleep Apnea: GLP-1 Drug Zepbound

With the effect of weight loss, it brings some short-term and long-term side effects

10.1016/j.lfs.2024.122638

It should only be prescribed for people in Wales and the UK for people living with type 2 diabetes." The Welsh government said: "Due to the extent and anticipated duration of the global supply disruption, in line with practice in all parts of the UK, people currently prescribed semaglutide will have their medication reviewed and, where necessary, an alternative treatment will be prescribed."

Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: A systematic review and meta-analysis of randomised trials

Journal of Drug Delivery Science and Technology